GLP-1 medications like Mounjaro and Saxenda might benefit stroke survivors and reduce some patients’ healthcare costs, according to researchers. 1. The use of Ozempic and Wegovy reduced healthcare ...

Aon researchers found that within two years, improved health outcomes for patients who were taking GLP-1 drugs lowers the growth rate of medical care costs. Aon looked at medical claims data for ...